Go Pro

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Unusually-High Trading Volume - Still a Buy?

Shionogi & Co., Ltd. Unsponsored ADR logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Trading volume surged 33% to approximately 175,605 shares, while Shionogi ADR shares rose 1.9% to $9.51.
  • Analyst sentiment improved, with Jefferies and Goldman Sachs upgrading the stock to “strong buy.” MarketBeat reports a consensus rating of “Buy” from two Strong Buy ratings and one Hold.
  • Shionogi exceeded quarterly expectations, reporting $0.36 in earnings per share versus the $0.18 consensus and revenue of $1.04 billion against estimates of $970.69 million.
  • Five stocks we like better than Shionogi & Co., Ltd. Unsponsored ADR.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 175,605 shares changed hands during trading, an increase of 33% from the previous session's volume of 132,286 shares.The stock last traded at $9.51 and had previously closed at $9.14.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a "strong sell" rating to a "hold" rating in a research report on Monday, May 25th. Jefferies Financial Group raised Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 14th. Finally, The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a research note on Monday, June 15th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Buy".

View Our Latest Research Report on Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 1.9%

The stock has a market capitalization of $16.24 billion, a price-to-earnings ratio of 9.54, a price-to-earnings-growth ratio of 3.38 and a beta of 0.08. The company has a current ratio of 1.58, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01. The firm's 50 day simple moving average is $8.88 and its 200-day simple moving average is $9.70.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.18 by $0.18. The firm had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 16.47% and a net margin of 46.67%. Equities analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.8 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

(Get Free Report)

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company's product portfolio spans both established and innovative therapies.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Shionogi & Co., Ltd. Unsponsored ADR Right Now?

Before you consider Shionogi & Co., Ltd. Unsponsored ADR, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. Unsponsored ADR wasn't on the list.

While Shionogi & Co., Ltd. Unsponsored ADR currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines